Vitamin D in rheumatoid arthritis—towards clinical application.

Rheumatoid Arthritis

Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level

Clin Rheumatol.

Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, He L

doi: 10.1007/s10067-017-3874-4.

Rheumatoid Arthritis

Association between Vitamin D deficiency and disease activity, disability and radiographic progression in early rheumatoid arthritis. The ESPOIR cohort

J Rheumatol.

Mouterde G, Gamon E, Rincheval N, Lukas C, Seror R, Berenbaum F, Dupuy AM, Daien C, Daurès JP, Combe B

doi: 10.3899/jrheum.190795.

Juvenile Idiopathic Arthritis

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Arthritis Res Ther.

Sengler C, Zink J, Klotsche J, Niewerth M, Liedmann I, Horneff G, Kessel C, Ganser G, Thon A, Haas JP, Hospach A, Weller-Heinemann F, Heiligenhaus A, Foell D, Zink A, Minden K

doi: 10.1186/s13075-018-1765-y.

Rheumatoid Arthritis

Measuring inflammatory foot disease in rheumatoid arthritis: development and validation of the Rheumatoid Arthritis Foot Disease Activity Index-5

Arthritis Care Res (Hoboken).

Hoque A, Gallagher K, McEntegart A, Porter D, Steultjens M, Woodburn J, Hendry GJ

doi: 10.1002/acr.24259.

Rheumatoid Arthritis

Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Rheumatology (Oxford).

Leu JH, Adedokun OJ, Gargano C, Hsia EC, Xu Z, Shankar G

doi: 10.1093/rheumatolog/key309.

Rheumatoid Arthritis

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Arthritis Res Ther.

Emery P, Tanaka Y, Cardillo T, Schlichting D, Rooney T, Beattie S, Helt C, Smolen JS

doi: 10.1186/s13075-020-02199-8.

Psoriatic ArthritisRheumatoid Arthritis

Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission

Clin Exp Rheumatol.

Ramírez J, Iniciarte-Mundo J, Cuervo A, Ruiz-Esquide V, Hernández MV, Sanmartí R, Cañete JD

Juvenile Idiopathic ArthritisRheumatoid ArthritisSpinal Disorders

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial

Arthritis Res Ther

Stockfelt M, Lundell AC, Hetland ML, Østergaard M, Uhlig T, Heiberg MS, Haavardsholm EA, Nurmohamed MT, Lampa J, Nordström D, Petersen KH, Gudbjornsson B, Gröndal G, Aldridge J, Andersson K, Blennow K, Zetterberg H, van Vollenhoven R, Rudin A

doi: 10.1186/s13075-021-02556-1

Rheumatoid Arthritis

Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Ann Rheum Dis.

Takeuchi T, Thorne C, Karpouzas G, Sheng S, Xu W, Rao R, Fei K, Hsu B, Tak PP

doi: 10.1136/annrheumdis-

Related content

Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level

Association between Vitamin D deficiency and disease activity, disability and radiographic progression in early rheumatoid arthritis. The ESPOIR cohort

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Measuring inflammatory foot disease in rheumatoid arthritis: development and validation of the Rheumatoid Arthritis Foot Disease Activity Index-5

Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial

Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study